Leland Gershell

Leland Gershell

Analyst-Equity chez
Oppenheimer & Co., Inc. (Broker)
54 ans
Finance
Health Technology
Consumer Services

Profil

Dr. Leland Gershell is a Managing Director & Senior Analyst at Oppenheimer & Co., Inc. He covers BioPharmaceuticals.
Prior to joining Oppenheimer, Dr. Gershell was Chief Financial Officer of Capricor Therapeutics and Tonix Pharmaceuticals.
He also has both sell-side and buy-side experience and began his career on Cowen's biotechnology research team, where he provided sole coverage focused in the small and mid-cap segment.
Dr. Gershell earned his M.D.
and Ph.D.
in Organic Chemistry from Columbia University and his B.A. magna cum laude in Chemistry and Asian Studies from Dartmouth College.

Postes actifs de Leland Gershell

SociétésPosteDébut
Analyst-Equity 01/02/2018

Anciens postes connus de Leland Gershell

SociétésPosteFin
CAPRICOR THERAPEUTICS, INC. Directeur Financier/CFO 01/01/2018
TONIX PHARMACEUTICALS HOLDING CORP. Directeur Financier/CFO 08/01/2016
Analyst-Equity 31/03/2012
Corporate Officer/Principal 01/10/2010
Analyst-Equity 31/05/2010
Voir l'expérience en détail de Leland Gershell

Formation de Leland Gershell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

100 +

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Finance

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Finance

Finance

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. Leland Gershell
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇